Dl. Eaton et al., ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY, Pharmacogenetics, 5(5), 1995, pp. 259-274
Cytochrome P4501A2 (CYP1A2) has been identified as a key factor in the
metabolic activation of numerous chemical carcinogens, including afla
toxin B-1, various heterocyclic and aromatic amines, and certain nitro
aromatic compounds. In addition, CYP1A2 contributes to the inactivatio
n of several common drugs and dietary constituents, including acetamin
ophen and caffeine, Two xenobiotic-responsive-element (XRE)-like seque
nces and an antioxidant response element (ARE) have been identified in
the regulatory region of the CYP1A2 gene; however, the functionality
of the ARE remains to be demonstrated. Based on in vivo phenotyping as
says, substantial interindividual variability in CYP1A2 activity has b
een reported. Some population-based studies have reported either bi- o
r tri-modal distributions in CYP1A2 phenotype, suggesting a genetic ba
sis for the large interindividual differences in CYP1A2 activity. Howe
ver, despite the polymodal distributions reported for CYP1A2 activity,
a distinct functional genetic polymorphism in the gene has not been i
dentified. Potential mechanisms contributing to the large interindivid
ual variability in CYP1A2 activity are discussed, A thorough understan
ding of the functions and regulation of the CYP1A2 gene may ultimately
lead to new methods for preventing or intervening in the development
of certain chemically-related human cancers.